Duggan Veterinary becomes the 27th member of Access Vetmed, a highly respected European organisation whose mission it is to increase ACCESS –availability, compliance, convenience, efficacy, safety, and savings – of veterinary medicines to veterinarians, and farm and companion animal owners in Europe. At the time of its foundation in 2002, a harmonised regulatory framework for product licensing in the EU was missing. This brought about the need to establish an association that would promote a harmonised EU system. Today, Access Vetmed strives to:

  • be the voice of the generic and added-value veterinary medicines industry in Europe,
  • represent the interests of European based manufacturers, including the SMEs in animal health sector,
  • facilitate access to veterinary medicines in Europe and promote responsible use as part of One Health approach,
  • raise awareness of the quality, safety, efficacy and other benefits, of the generic and added – value veterinary medicines for animals, humans and the society,
  • ensure availability of medicines in all EU countries,
  • work actively and constructively with the EU regulators and other stakeholders for transparent, harmonised, pragmatic and balanced animal health regulation,
  • keep our members well informed about and engage them in the European regulatory issues and help them adapt to changing requirements, and
  • raise national competent authorities’, and national and EU trade associations’ awareness of generic veterinary medicines.

“I am very pleased to welcome Duggan Veterinary Supplies into our association,” Access Vetmed Chair Xavier Molins said. “Together as an industry, we can continue our dedicated work to improve access to generic and added-value veterinary medicines and strengthen its significance in Europe”.

Access Vetmed works closely with regulators and decision-makers to overcome the regulatory difficulties experienced by members. Through active participation and constructive discussion, the organisation aims to achieve a practical, harmonised and coherent approach for the licensing of generic veterinary products in Europe.

On its new membership, Brian O’Callaghan, stated: “We are very appreciative and proud of the opportunity to join Access Vetmed in 2023, where we will look to collaborate and continue to develop strategies with added input from our peers and colleagues within the European veterinary industry.”